Investigational new drugs for allergic rhinitis.

about

Mahuang Fuzi Xixin Decoction Attenuates Th1 and Th2 Responses in the Treatment of Ovalbumin-Induced Allergic Inflammation in a Rat Model of Allergic Rhinitis.Mesenchymal stromal cells ameliorate acute allergic rhinitis in rats.

P2860

Q38645692-952EBD29-CE9C-476A-9E96-39FA27C253FE Q47131881-6A8DDF88-28AD-441A-9FAA-7372BACC662B

P2860

Investigational new drugs for allergic rhinitis.

Item

http://www.wikidata.org/entity/Q39111947

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Investigational new drugs for allergic rhinitis.

@en

Investigational new drugs for allergic rhinitis.

@nl

type

Item

label

Investigational new drugs for allergic rhinitis.

@en

Investigational new drugs for allergic rhinitis.

@nl

prefLabel

Investigational new drugs for allergic rhinitis.

@en

Investigational new drugs for allergic rhinitis.

@nl

P1476

Investigational new drugs for allergic rhinitis.

@en

P2093

Chen Hsing Lin

http://www.w3.org/2001/XMLSchema#string

Peter A Ricketti

http://www.w3.org/2001/XMLSchema#string

Sultan Alandijani

http://www.w3.org/2001/XMLSchema#string

Thomas B Casale

http://www.w3.org/2001/XMLSchema#string

P2860

Immunological mechanisms of allergen-specific immunotherapy

Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit.

Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis

Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma.

Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents.

A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis.

Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.

Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.

Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis: A Systematic Review and Meta-analysis.

P304

279-292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543784.2017.1290079

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28141955

http://www.w3.org/2001/XMLSchema#string

Investigational new drugs for allergic rhinitis.

about

P2860

P2860

Investigational new drugs for allergic rhinitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698